Pharmather Holdings LtdOTCQB:PHRRFView on Canadian Exchange
- LAST PRICE0.1659
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1640/ 60
- Ask / Lots0.1678/ 50
- Open / Previous Close0.1673 / 0.1659
- Day Range
- 52 Week Range
- Volume16,115
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PHRRF |
|---|---|---|
| 09:32 ET | 666 | 0.1673 |
| 09:52 ET | 7350 | 0.1678 |
| 09:57 ET | 100 | 0.1659 |
| 10:10 ET | 1665 | 0.1659 |
May 15, 2024
PharmaTher's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine, from 8:00AM ET on Wednesday May 15, 2024 by Dow Jones
8:00AM ET on Wednesday May 15, 2024 by Dow Jones
May 10, 2024
PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug Application for Ketamine, from 7:59AM ET on Friday May 10, 2024 by Dow Jones
7:59AM ET on Friday May 10, 2024 by Dow Jones
May 1, 2024
PharmaTher's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine, from 8:00AM ET on Wednesday May 01, 2024 by Dow Jones
8:00AM ET on Wednesday May 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pharmather Holdings Ltd | 19.0M | 0.0x | --- |
Company Information
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.
Contact Information
- Headquarters
- 82 Richmond Street EastTORONTO, BC, Canada M5C 1P1
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $19.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 88.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.32 |
EPS | $-0.05 |
Book Value | $0.06 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
